Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Ethic Comitte (CONEP) determinated the prematurely terminated.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 200 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 10 centers.
Any patient receiving a market-approved SJM Quadra Assura MP (CRT-D) or newer model quadripolar device with MPP capability and who meets the inclusion criteria and none of the exclusion criteria is eligible for enrollment in the study.
Patients will be followed for 12 months after implant. Data will be collected after device implant (up to 30 days after successful implant), at 3, 6 and 12 months post-implant and during unscheduled visits.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Single group - observational |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Observational | Other | Device: MultiPoint Pacing will be enabled in enrolled patients at the discretion of the physician. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cardiac resynchronization therapy response rate measured by Clinical Composite Score | Evaluated on regular medical visits and registered in the CRF | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life changes, measured by MLWHF questionnaire | Evaluated on regular medical visits and registered in the CRF | 12 months |
| Quality of Life changes, measured by EQ-5D questionnaire | Evaluated on regular medical visits and registered in the CRF |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Any patient receiving a market-approved SJM Quadra Assura MP (CRT-D) or newer model quadripolar device with MPP capability and who meets the inclusion criteria and none of the exclusion criteria is eligible for enrollment in the study.
Patients will be followed for 12 months after implant. Data will be collected after device implant (up to 30 days after successful implant), at 3, 6 and 12 months post-implant and during unscheduled visits.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marco Aurelio Santos | Abbott Medical Devices | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinica Dom Rodrigo | João Pessoa | Paraíba | Brazil | |||
| BP |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D057832 | Watchful Waiting |
| ID | Term |
|---|---|
| D017063 | Outcome Assessment, Health Care |
| D010043 | Outcome and Process Assessment, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 months |
| Change in left ventricular ejection fraction | Evaluated on regular medical visits and registered in the CRF | 12 months |
| Change in left ventricular end systolic volume | Evaluated on regular medical visits and registered in the CRF | 12 months |
| Programming strategy used (vector and intervals), obtained from the Device Session records | Evaluated on regular medical visits and registered in the CRF | 12 months |
| Heart failure hospitalization rate | Evaluated on regular medical visits and registered in the CRF | 12 months |
| All-cause mortality | Evaluated on regular medical visits and registered in the CRF | 12 months |
| São Paulo |
| São Paulo |
| 01323-001 |
| Brazil |
| Instituto de Arritmias Cardíacas | São Paulo | São Paulo | 01323-001 | Brazil |
| SEMAP | São Paulo | São Paulo | 04.004-030 | Brazil |